IFNG and gastric cancer: To the best of our knowledge, this is the first study showing that the tumor suppressor, PML, regulates IP-10 chemokine transcription and lymphocyte trafficking in gastric cancer, by modulating the activity of the IFN-γ/STAT-1 signaling pathway.